Key Drivers
- Thin margins
- Recent quarterly loss
- Strong cash reserves
AIAI Summary
ALHC has shifted from a pure enrollment growth story to a scaled Medicare Advantage operator where margin expansion via AVA/tech-enabled care and gross‑profit‑per‑member improvement—not membership alone—will determine valuation, so investors should condition their thesis on the company consistently delivering realized gross profit per member and durable adjusted EBITDA/FCF. Key actionable watchpoints: verify sequential gross‑profit‑per‑member beats, sustained positive free cash flow beyond seasonal swings, and whether RADV/Part D adjustments or insider selling abate before assuming current rich multiples.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Thin margins
- •Recent quarterly loss
- •Strong cash reserves
ALHC delivers scale and annual free cash flow but suffers from very thin margins, a recent quarterly loss, high leverage versus equity, and rich valuation multiples—raising short‑term operating and valuation risk.
Price Behavior
Key Price Behavior Insights:
- •Below last-month SMA
- •Near-oversold RSI
- •Defined support zone
ALHC is in a short-term downtrend, trading below its last-month SMA (~$18.64) with RSI ~32 and immediate support at $16.99–$17.12 versus resistance near $20.40 and heavier at $22.89.
Price fell from the last-month
Sentiment & News
Key News Insights:
- •Beat guidance
- •Secondary offering
- •Institutional reshuffle
Alignment Healthcare beat Q4/FY2025 guidance and EPS estimates but saw an intraday sell-off amid active institutional repositioning and a large underwritten secondary by a prior major holder.
The operational beat is positive, but the sizable secondary and heavy insider selling create near-term downward pressure on the stock despite improved metrics
Similar Companies in Healthcare
Other companies in the same sector with AI ratings